NasdaqGS - Delayed Quote • USD
Align Technology, Inc. (ALGN)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 7:53 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 15 | 15 |
| Avg. Estimate | 1.97 | 2.38 | 9.28 | 10.51 |
| Low Estimate | 1.88 | 2.23 | 8.05 | 8.89 |
| High Estimate | 2.03 | 2.46 | 9.69 | 11.34 |
| Year Ago EPS | 1.82 | 2.22 | 8.61 | 9.28 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 14 | 14 |
| Avg. Estimate | 974.41M | 1.03B | 4.05B | 4.47B |
| Low Estimate | 967.8M | 1.01B | 3.99B | 4.32B |
| High Estimate | 988.4M | 1.05B | 4.09B | 5.06B |
| Year Ago Sales | 943.15M | 1B | 3.86B | 4.05B |
| Sales Growth (year/est) | 3.30% | 3.00% | 4.80% | 10.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.68 | 2.03 | 2.26 | 2.18 |
| EPS Actual | 1.82 | 2.22 | 2.14 | 2.42 |
| Difference | 0.14 | 0.19 | -0.12 | 0.24 |
| Surprise % | 8.30% | 9.40% | -5.30% | 11.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.97 | 2.38 | 9.28 | 10.51 |
| 7 Days Ago | 1.96 | 2.38 | 9.26 | 10.5 |
| 30 Days Ago | 1.96 | 2.38 | 9.26 | 10.5 |
| 60 Days Ago | 1.97 | 2.38 | 9.28 | 10.5 |
| 90 Days Ago | 2.06 | 2.34 | 9.17 | 10.62 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 2 |
| Up Last 30 Days | 1 | 1 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | ALGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 8.20% | -- | -- | 0.80% |
| Next Qtr. | 7.20% | -- | -- | 9.60% |
| Current Year | 7.80% | -- | -- | 4.50% |
| Next Year | 13.30% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 12.50% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 13.14% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 4/18/2024 |
| Maintains | UBS: Neutral to Neutral | 4/15/2024 |
| Maintains | Stifel: Buy to Buy | 3/15/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 3/13/2024 |
| Initiated | Leerink Partners: Market Perform | 2/26/2024 |
| Maintains | Goldman Sachs: Sell to Sell | 2/2/2024 |
Related Tickers
DXCM DexCom, Inc.
134.30
+0.33%
SYK Stryker Corporation
327.45
-2.55%
PODD Insulet Corporation
164.73
-0.92%
EW Edwards Lifesciences Corporation
86.45
-0.91%
BIO Bio-Rad Laboratories, Inc.
281.02
-3.38%
INSP Inspire Medical Systems, Inc.
241.15
-0.97%
MASI Masimo Corporation
135.92
-0.51%
BSX Boston Scientific Corporation
67.42
-0.79%
ABT Abbott Laboratories
105.27
-0.59%
SWAV Shockwave Medical, Inc.
327.52
+0.01%